By Manufacturing Process

Targeted Enrichment / Hybrid Capture NGS Market Analysis

Cross-industry research covering Targeted Enrichment / Hybrid Capture NGS across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports
1 Industries

Reports Covering Targeted Enrichment / Hybrid Capture NGS

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Hybrid capture enrichment panels (exome capture, custom disease panels) are manufactured by Roche NimbleGen, Twist Bioscience, and IDT, and represent the manufacturing substrate for most clinical-grade DTC panels.

9%

Market Share

8.4%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments